Necrotizing fasciitis associated with injection drug use

Area of Science:

• Infectious Diseases
• Dermatology
• Public Health

Background:

• Necrotizing fasciitis is a rapidly progressive bacterial infection of the deep subcutaneous tissues and fascia.
• Injection drug use (IDU) is an emerging risk factor for severe skin and soft tissue infections, including necrotizing fasciitis.
• Understanding risk factors and outcomes is essential for timely diagnosis and management.

Purpose of the Study:

• To compare the clinical characteristics and outcomes of necrotizing fasciitis in injection drug users (IDUs) versus non-IDUs.
• To identify risk factors associated with necrotizing fasciitis in both populations.
• To evaluate the mortality rates and treatment requirements for necrotizing fasciitis in IDUs and non-IDUs.

Main Methods:

• Retrospective case series analysis of 107 patients with necrotizing fasciitis.
• Patients were categorized into injection drug users (IDUs) and non-IDUs.
• Data collected included demographics, risk factors (e.g., injection sites, insect bites, wounds), surgical debridements, and mortality.

Main Results:

• Of 107 patients, 59% were IDUs. IDUs frequently reported recent injections at the infection site (54%) or presented with abscesses (29%).
• Non-IDUs reported insect bites (35%) or wounds/abrasions (19%).
• Overall mortality was 15% (10% for IDUs, 21% for non-IDUs). Extensive debridement was common in both groups.

Conclusions:

• A high index of suspicion for necrotizing fasciitis is warranted in patients with cellulitis, insect bites, wounds, or recent injection drug use.
• IDUs represent a significant proportion of necrotizing fasciitis cases, with specific risk factors related to injection practices.
• Targeted preventive strategies, including education and prompt abscess/cellulitis treatment for IDUs, are recommended.